Altered adrenal function as an inducer of latent chronic beryllium disease.
D000311:Adrenal Glands / Q000187:drug effects / Q000503:physiopathology*; D000469:Alkaline Phosphatase / Q000097:blood; D000818:Animals; D001607:Berylliosis; D001608:Beryllium / Q000032:analysis / Q000652:urine; D001835:Body Weight / Q000187:drug effects; D001842:Bone and Bones / Q000032:analysis; D002908:Chronic Disease; D004305:Dose-Response Relationship, Drug; D005260:Female; D006168:Guinea Pigs; D007521:Isocitrate Dehydrogenase / Q000097:blood; D008099:Liver / Q000032:analysis; D008168:Lung / Q000032:analysis; D008171:Lung Diseases / Q000139:chemically induced / Q000503:physiopathology; D008297:Male; D008797:Metyrapone / Q000494:pharmacology; D051379:Mice; D009929:Organ Size; D011041:Poisoning / Q000503:physiopathology; D011868:Radioisotopes; D012737:Sex Factors; D013154:Spleen / Q000032:analysis; D013997:Time Factors
D011868:Radioisotopes; D007521:Isocitrate Dehydrogenase; D000469:Alkaline Phosphatase; D001608:Beryllium; D008797:Metyrapone